LuxCreo and EMA Sleep start 3D printing production for individual apnea devices

Die Zusammenarbeit zwischen LuxCreo, Inc. and EMA Sleep, Inc. Markiert einen bedeutenden Schritt in der personalized Medizintechnik. Ziel ist die Herstellung und Skalierung des EMA-Geräts zur Behandlung der obstruktiven Schlafapnoe (OSA) direktt en Kliniken. OSA has paid more than 40 million Americans* and can have unexpected losses like lost income and losses every time.

Das EMA-Gerät, vor über three Jahrzehnten von Dr. Don Frantz entwickelt, arbeitet durch das Öffnen des Bisses and the vorsichtige Vorverlegen des Unterkiefers mittels elastischer Gurte, um den Luftweg zu erweitern. Bisher wurde das FDA-zugelassene Klasse-II-Gerät manuall mittels Thermoforming hergestellt, was die breite Einführung aufgrund technischer et logistischer Einschränkungen erschwerte.

Sonnie Bocala, industry veterinarian and engineering expert from EMA Sleep, explained the work of LuxCreo: “I can’t create the LuxCreo team. This is why LuxCreo’s custom platform for medical institutions presents many problems for your skin. We now suggest that you use a software solution, the one provided by the EMA agency – and LuxCreo is there for you. This is a technical support service or quick response service, which must be used by the company LuxCreo-Organisation.

In January 2024, we proposed two solutions for the next generation of EMA devices: a new FDA 510(k) standard for 3D printing of EMA devices (K232735). For others, EMA Sleep features the LuxCreos iLux Pro dental platform, a universal design and printing design, the best production solution. This platform enables 3D EMA design directly through automated design software, a complete production system and a clean, FDA-formulated product.

“It has happened that the global MedTech branch reaches 500 billion dollars until 2032 beyond 800 billion dollars. LuxCreo has a service offering for this region, apart from this, emergency medical services are directed directly to the management organization, which has a constant influence on patients”, said Michael Strohecker. , Mitbegründer and Chief Revenue Officer of LuxCreo. “Sonnie, Joe Frantz and their team within Schlafapnoe management across all patient groups were able to see LuxCreo’s customized platform to help them realize.”

The partnership took place on September 28, 2024 at the launch of LuxCreo’s National Education Centers in Chicago. This article understands the strong integration of 3D printing technology in personalized medicine and offers a verbesserte approach for the patient*innen mit Schlafapnoe.